Sunday November 22 2009 | Biotechnology feed | All feeds
|
|
Domantis Inc
Download detailed PDF Members: Domantis Limited was launched in December 2000 by Sir Gregory Winter and Dr Ian Tomlinson of the MRC–LMB with the backing of the MRC and MVM Limited to commercialise Domain Antibody products. To date, Domantis has raised a total of $83M, most recently attracting additional $29 million in a Series B prime venture financing in December 2005 from new investors Novo Nordisk and MC Life Science Ventures, Inc. (a subsidiary of Mitsubishi Corporation), together with its existing investors which included 3i, MVM and Peptech Limited. These funds are being used to expand Domantis' portfolio of proprietary dAb therapeutic leads and to advance certain dAb leads toward clinical trials. Today, Domantis has over 55 employees, including a core scientific group in Domain Antibody discovery and development and scientists involved Domain Antibody Technology and product development. Domantis' R & D laboratories are located on the Cambridge Science Park in Cambridge, UK and its commercial offices are located in Waltham, Massachusetts, USA
This page has been viewed 583 times since April 2007, the link to the organisation's website has been followed 130 times Recent Search Terms used to find this page: Domantis domain antibody | domantis waltham | total raised domantis | Domantis financing | Domantis Inc. | domantis science park cambridge | Domantis Inc. | domantis mvm | domantis, inc waltham | domantis | . Search for more companies in Waltham Search for more companies in Massachusetts This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Domantis Inc | ||||||||||||||||||||||||||
|